Sensex and Nifty Performance Overview

The benchmark Sensex opened flat, down marginally by 45.26 points, but selling intensified through the session, culminating in a 0.57% decline. The index closed at 76,658.64, retreating from recent highs but still trading above its 50-day moving average (DMA). However, the 50DMA remains below the 200DMA, signalling a cautious medium-term technical outlook. The Nifty mirrored this trend, with a similar percentage decline, weighed down by heavyweight sectors.

Sectoral Trends: Pharma Leads, Auto Lags

Out of 38 sectors tracked, only six advanced while 32 declined, underscoring the broad market weakness. The Nifty Pharma sector was the top gainer, rising 0.95%, buoyed by strong performances from Ajanta Pharma and Zydus Wellness. Conversely, the Auto sector was the worst performer, falling 2.18%, pressured by weak demand outlook and profit booking. The technology sector also faced headwinds, with the S&P BSE Teck index hitting a new 52-week low, reflecting investor caution amid global tech sell-offs.

Market Breadth and Capitalisation Segments

Market breadth was decidedly negative with the advance-decline ratio across the BSE500 at 0.47x, as 158 stocks advanced against 337 decliners. Midcap and smallcap indices also fell, with the S&P BSE 150 Midcap index down 0.45% and the S&P BSE 250 Smallcap index declining 0.58%. The BSE100 index dropped 0.64%, indicating that weakness was not confined to smaller stocks but was broad-based across market capitalisation segments.

Top Gainers and Losers

Among the BSE500 constituents, Zydus Wellness led the gainers with an impressive 11.37% rise, followed by Schneider Electric India at 8.77% and Ajanta Pharma at 7.76%. These stocks benefited from sector-specific tailwinds and positive investor sentiment. On the downside, Netweb Technologies plunged 11.09%, Persistent Systems declined 9.99%, and Astral fell 8.31%, reflecting profit booking and sectoral pressures.

Foreign Institutional and Domestic Institutional Activity

Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) remained net sellers, contributing to the market’s downward momentum. The cautious global environment, coupled with domestic macroeconomic concerns, led to subdued buying interest. This institutional selling weighed heavily on large-cap stocks, particularly in technology and auto sectors.

Large Cap and Mid Cap Movers

Among large caps, Max Healthcare was the top gainer, rising 2.41%, supported by positive sectoral sentiment and expectations of robust earnings. Persistent Systems was the largest large-cap loser, plunging 9.99%, reflecting profit booking and sector rotation. Midcap stocks traded largely flat, with Ajanta Pharma standing out as the top midcap gainer at 7.76%. The smallcap segment saw Zydus Wellness surge 11.37%, while Netweb Technologies declined sharply by 11.09%.

Technical and Market Outlook

The Sensex’s position above its 50DMA offers some near-term support, but the fact that the 50DMA remains below the 200DMA suggests that the broader trend is still under pressure. The new 52-week low in the technology sector index signals continued weakness in that space. Investors are advised to monitor upcoming corporate results closely, including CMR Green Tech’s earnings announcement scheduled for 30 Jun 2026, which could provide fresh directional cues.

Global Cues and Their Impact

Global markets remained subdued amid concerns over inflationary pressures and geopolitical tensions, which dampened risk appetite. This cautious global backdrop influenced domestic investor sentiment, contributing to the broad-based declines seen in Indian markets. The weakness in technology stocks globally also weighed on the domestic tech sector, exacerbating losses.

Investor Takeaway

Today’s market action highlights the ongoing volatility and sector rotation within Indian equities. While the pharma sector continues to demonstrate resilience, sectors like auto and technology face headwinds. The broad market weakness and negative breadth suggest caution for investors, especially in mid and smallcap stocks. Institutional selling and global uncertainties remain key factors to watch in the near term. Investors should consider focusing on fundamentally strong stocks with consistent growth records and robust price momentum to navigate the current environment.

Upcoming Corporate Results

Market participants will be closely watching the earnings announcement of CMR Green Tech on 30 Jun 2026. The results could provide fresh impetus or caution depending on the company’s performance and outlook, potentially influencing sectoral and broader market trends.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today